DePuy, Inc.:市場シェア分析...市場調査レポートについてご紹介

【英文タイトル】DePuy, Inc. Market Share Analysis

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
3 Definitions of Markets/Categories Covered 14
3.1 Neurology Devices 14
3.1.1 CSF Management 14
3.1.2 Interventional Neurology 14
3.1.3 Neurological Diagnostic Equipment 14
3.2 Orthopedic Devices 14
3.2.1 Arthroscopy 14
3.2.2 Hip Reconstruction 14
3.2.3 Knee Reconstruction 14
3.2.4 Orthobiologics 15
3.2.5 Orthopedic Bone Cement and Casting Materials 15
3.2.6 Other Joint Reconstruction 15
3.2.7 Spinal Surgery 15
3.2.8 Trauma Fixation 15
4 Company Snapshot 16
4.1 Key Facts 16
4.2 Company Overview 16
4.3 SWOT Snapshot 16
4.4 Business Overview 17
4.5 Major Products and Services 18
4.5.1 Overview 18
5 History 20
6 SWOT Analysis 25
6.1 Overview 25
6.2 DePuy, Inc. Strengths 25
6.2.1 Synergy through Johnson & Johnson 25
6.2.2 Broad Range of Solutions 25
6.2.3 Technology Driven Products 26
6.3 DePuy, Inc. Weaknesses 26
6.3.1 Product Call Backs 26
6.3.2 Governmental Investigations 26
6.4 DePuy, Inc. Opportunities 27
6.4.1 Global Orthopaedic Devices Market 27
6.4.2 New Product Launches and Approvals 27
6.4.3 Expansion through Acquisitions 27
6.5 DePuy, Inc. Threats 28
6.5.1 Cost Containment Pressures 28
6.5.2 Rapid Technological Changes 28
6.5.3 Stringent Government Regulations 28
7 Competitors 29
8 Competitive Landscape 31
8.1 Neurology Devices (CSF Management), Global, Market Share (%), 2011 31
8.2 DePuy, Inc., Neurology Devices (CSF Management), by Region, Market Share (2011) 33
8.3 DePuy, Inc., Neurology Devices (CSF Management), by Country, Market Share (2011) 34
8.4 Neurology Devices (Interventional Neurology), Global, Market Share (%), 2011 36
8.5 DePuy, Inc., Neurology Devices (Interventional Neurology), by Region, Market Share (2011) 37
8.6 DePuy, Inc., Neurology Devices (Interventional Neurology), by Country, Market Share (2011) 38
8.7 Neurology Devices (Neurological Diagnostic Equipment), Global, Market Share (%), 2011 40
8.8 DePuy, Inc., Neurology Devices (Neurological Diagnostic Equipment), by Region, Market Share (2011) 42
8.9 DePuy, Inc., Neurology Devices (Neurological Diagnostic Equipment), by Country, Market Share (2011) 43
8.10 Orthopedic Devices (Arthroscopy), Global, Market Share (%), 2011 45
8.11 DePuy, Inc., Orthopedic Devices (Arthroscopy), by Region, Market Share (2011) 46
8.12 DePuy, Inc., Orthopedic Devices (Arthroscopy), by Country, Market Share (2011) 47
8.13 Orthopedic Devices (Hip Reconstruction), Global, Market Share (%), 2011 49
8.14 DePuy, Inc., Orthopedic Devices (Hip Reconstruction), by Region, Market Share (2011) 50
8.15 DePuy, Inc., Orthopedic Devices (Hip Reconstruction), by Country, Market Share (2011) 51
8.16 Orthopedic Devices (Knee Reconstruction), Global, Market Share (%), 2011 53
8.17 DePuy, Inc., Orthopedic Devices (Knee Reconstruction), by Region, Market Share (2011) 54
8.18 DePuy, Inc., Orthopedic Devices (Knee Reconstruction), by Country, Market Share (2011) 55
8.19 Orthopedic Devices (Orthobiologics), Global, Market Share (%), 2011 57
8.20 DePuy, Inc., Orthopedic Devices (Orthobiologics), by Region, Market Share (2011) 59
8.21 DePuy, Inc., Orthopedic Devices (Orthobiologics), by Country, Market Share (2011) 60
8.22 Orthopedic Devices (Orthopedic Bone Cement and Casting Materials), Global, Market Share (%), 2011 62
8.23 DePuy, Inc., Orthopedic Devices (Orthopedic Bone Cement and Casting Materials), by Region, Market Share (2011) 64
8.24 DePuy, Inc., Orthopedic Devices (Orthopedic Bone Cement and Casting Materials), by Country, Market Share (2011) 65
8.25 Orthopedic Devices (Other Joint Reconstruction), Global, Market Share (%), 2011 67
8.26 DePuy, Inc., Orthopedic Devices (Other Joint Reconstruction), by Region, Market Share (2011) 69
8.27 DePuy, Inc., Orthopedic Devices (Other Joint Reconstruction), by Country, Market Share (2011) 70
8.28 Orthopedic Devices (Spinal Surgery), Global, Market Share (%), 2011 72
8.29 DePuy, Inc., Orthopedic Devices (Spinal Surgery), by Region, Market Share (2011) 74
8.30 DePuy, Inc., Orthopedic Devices (Spinal Surgery), by Country, Market Share (2011) 75
8.31 Orthopedic Devices (Trauma Fixation), Global, Market Share (%), 2011 77
8.32 DePuy, Inc., Orthopedic Devices (Trauma Fixation), by Region, Market Share (2011) 79
8.33 DePuy, Inc., Orthopedic Devices (Trauma Fixation), by Country, Market Share (2011) 80
9 DePuy, Inc. Medical Equipment Market Share Analysis by Category 82
9.1 DePuy, Inc., Global, Category Revenue Share (2011) 82
9.2 DePuy, Inc., Asia-Pacific, Category Revenue Share (2011) 85
9.2.1 DePuy, Inc., Australia, Category Revenue Share (2011) 88
9.2.2 DePuy, Inc., China, Category Revenue Share (2011) 91
9.2.3 DePuy, Inc., India, Category Revenue Share (2011) 94
9.2.4 DePuy, Inc., Japan, Category Revenue Share (2011) 97
9.2.5 DePuy, Inc., Other Asia-Pacific, Category Revenue Share (2011) 100
9.3 DePuy, Inc., Europe, Category Revenue Share (2011) 103
9.3.1 DePuy, Inc., France, Category Revenue Share (2011) 106
9.3.2 DePuy, Inc., Germany, Category Revenue Share (2011) 109
9.3.3 DePuy, Inc., Italy, Category Revenue Share (2011) 112
9.3.4 DePuy, Inc., Spain, Category Revenue Share (2011) 115
9.3.5 DePuy, Inc., United Kingdom, Category Revenue Share (2011) 118
9.3.6 DePuy, Inc., Other Europe, Category Revenue Share (2011) 121
9.4 DePuy, Inc., Middle East and Africa, Category Revenue Share (2011) 124
9.5 DePuy, Inc., North America, Category Revenue Share (2011) 127
9.5.1 DePuy, Inc., Canada, Category Revenue Share (2011) 130
9.5.2 DePuy, Inc., United States, Category Revenue Share (2011) 133
9.6 DePuy, Inc., South and Central America, Category Revenue Share (2011) 136
9.6.1 DePuy, Inc., Brazil, Category Revenue Share (2011) 139
9.6.2 DePuy, Inc., Other South and Central America, Category Revenue Share (2011) 142
10 Key Employees 145
11 Company Statement 146
12 Locations And Subsidiaries 147
12.1 Head Office 147
12.2 Other Locations & Subsidiaries 147
13 Financial Deals Landscape 148
13.1 DePuy, Inc., Deals Volume Summary, 2007 to 2012 148
14 DePuy, Inc., Deals Summary By Region, 2007 to 2012 149
15 Recent Developments 151
15.1 Strategy And Business Planning 151
15.1.1 Aug 11, 2009: DePuy Opens Global Institute For Education, Training, Research Across Continuum Of Orthopaedic And Neurological Care 151
15.1.2 Jun 11, 2008: DePuy Plans To Close Its Distribution Warehouse In Leeds 151
15.2 Research And Development 152
15.2.1 Jul 25, 2011: DePuy Opens Institute For Advanced Education And Research In Orthopedic And Neurological Care In India 152
15.3 Corporate Communications 153
15.3.1 Jan 08, 2008: DePuy Appoints Group Chairman 153
15.4 Legal and Regulatory 153
15.4.1 Jan 19, 2013: J&J Likely To Reach $2 Billion Settlement Over Hip Implants Lawsuits 153
15.4.2 Apr 14, 2011: Law Offices Of John David Hart Files Five Lawsuits Against DePuy And J&J Regarding Failed Hip Devices In Houston, Texas 153
15.4.3 Jun 26, 2006: DePuy Receives Subpoena On Manufacturing And Sales Practices 154
15.5 Product News 154
15.5.1 Aug 08, 2012: Codman Receives FDA PMA Approval For MEDSTREAM Programmable Infusion System 154
15.5.2 Feb 15, 2012: DePuy Receives FDA PMA Supplement Approval For TRUMATCH Personalized Solutions With SIGMA Rotating Platform Knee System 155
15.5.3 Dec 06, 2011: DePuy Spine Launches EXPEDIUM Neuromuscular System 156
15.5.4 Nov 14, 2011: Codman Launches CERTAS Programmable Valve For Hydrocephalus 156
15.5.5 Aug 19, 2011: Depuy Receives FDA 510(k) Clearance For TRUMATCH Personalized Solutions 157
15.5.6 May 05, 2011: Doctors In Germany Among First To Use New REVIVE SE For Ischemic Stroke: Depuy 157
15.5.7 Apr 26, 2011: Codman Announces European Launch Of CODMAN CERTAS Programmable Valve 158
15.5.8 Feb 14, 2011: DePuy Receives FDA 510(k) Approval For New Titanium Foam Implants 159
15.5.9 Feb 14, 2011: Depuy Receives FDA 510(K) Clearance For RECLAIM Revision Hip System 159
15.5.10 Oct 05, 2010: DePuy Spine Introduces COUGAR LS Cage System And EXPEDIUM Offset System At NASS 160
15.5.11 Aug 26, 2010: DePuy Orthopaedics Voluntarily Recalls ASR XL Acetabular System And ASR Hip Resurfacing System 160
15.5.12 Aug 24, 2010: FDA Warns Depuy For Illegally Marketing Corail Hip System And TruMatch Personalized Solution System 160
15.5.13 Jul 13, 2010: DePuy Launches Sigma High Performance Partial Knee In Europe 161
15.5.14 Jul 11, 2010: DePuy Introduces Sigma CR-150 Knee Joint Implant In India 162
15.5.15 May 25, 2010: National Joint Registry Issues Medical Device Alert For the Depuy ASR Acetabular Cup 162
15.5.16 Apr 26, 2010: DePuy Spine Introduces EXPEDIUM Vertebral Body Derotation Instrument Set 163
15.5.17 Nov 11, 2009: DePuy Spine Launches UNIPLATE 2 Anterior Cervical Plate System And VERTIGRAFT VG2 Cervical Allograft With PRESERVON Technology 163
15.5.18 Aug 18, 2009: Depuy Announces FDA Administration Panel Recommendation For Approval Of Pinnacle CoMplete Acetabular Hip System 164
15.5.19 Apr 28, 2009: Depuy Spine Announces The Launch Of Healos Fx Injectable Bone Graft Replacement For Minimally Invasive Spine Procedures 165
15.5.20 Feb 25, 2009: DePuy Orthopaedics Introduces New Metal Head For Hip, Significantly Reduces Wear And Potential For Ion Release 165
15.5.21 Feb 25, 2009: DePuy Orthopaedics Sigma Knee Portfolio Advances Options With New High Flexion Partial And Total Knee Solutions 166
15.5.22 Feb 25, 2009: DePuy Orthopaedics’ Anatomic Locked Plating Systems (A.L.P.S.) For Trauma Available For Hand And Distal Fibula Fractures 167
15.5.23 Feb 25, 2009: DePuy Orthopaedics’ Sigma Knee Portfolio Advances Options With New High Flexion Partial And Total Knee Solutions 168
15.5.24 Sep 12, 2008: Depuy Orthopaedics Inc Introduces LCS Complete RPS Flexion Knee 169
15.5.25 Jun 20, 2008: Depuy Spine Launches Next Generation Swift Anterior Cervical Plating System 169
15.5.26 Jun 02, 2008: Depuy Spine Launches Confidence System For Vertebral Compression Fractures At Spineweek 169
15.5.27 May 23, 2008: Depuy Spine Introduces New Vertigraft VG2 TLIF Allograft – Unique Construction Facilitates Bone Growth, Streamlined Insertion Technique 170
15.5.28 May 22, 2008: Depuy Spine Launches New Expedium Peek Rod System – Load Sharing Design, Imaging Compatibility, System Versatility 170
15.5.29 May 06, 2008: Depuy Spine Introduces New Minimally Invasive VIPER 2 Pedicle Screw Fixation System For Complex Spine Procedures 171
15.5.30 May 06, 2008: Depuy Spine Introduces New Vertigraft VG1 Cervical Allograft -Shaped To Align With Anatomy, Freeze-Dried For Easy Storage 171
15.5.31 Apr 18, 2008: Depuy Spine Launches New Expedium 4.5 Spine System For Treating Deformity In Small-Stature Patients 171
15.5.32 Mar 10, 2008: Depuy Spine Poised For Continued Growth: AEGIS Anterior Lumbar Plate System 172
15.5.33 Mar 10, 2008: Depuy Spine Poised For Continued Growth: VG2 TLIF Allograft 172
15.5.34 Mar 05, 2008: Depuy Orthopaedics Inc. Launches New Anatomic Locked Plating Systems 172
15.5.35 Mar 05, 2008: Depuy Orthopaedics Launches Pinnacle Hip Solutions With Trueglide Technology 173
15.5.36 Mar 05, 2008: DePuy Orthopaedics Launches Sigma CR Porocoat Femur 173
15.5.37 Mar 05, 2008: Depuy Orthopaedics Launches Sigma PS Femur 173
15.5.38 Nov 06, 2007: Depuy Launches New Software For Computer-Assisted Knee Surgery 174
15.5.39 Sep 26, 2007: Depuy Mitek Introduces Next Generation Suture Passer For Arthroscopic Shoulder Repair 174
15.5.40 Sep 25, 2007: Ankle Replacement Compares Favorably To Ankle Fusion According To A New Peer-Reviewed Study 174
15.5.41 Sep 08, 2007: DePuy Mitek Introduces New BIOKNOTLESS BR Bioreplaceable Suture Anchors 175
15.5.42 Sep 08, 2007: DePuy Mitek Introduces New LUPINE BR Bioreplaceable Suture Anchors 175
15.5.43 Jul 27, 2007: Depuy Launches New Software For Computer-Assisted Hip Surgery 175
15.5.44 Feb 12, 2007: Depuy Orthopaedics To Unveil F3 Fragment Plating System At American Academy Of Orthopaedic Surgeons Annual Meeting 176
15.5.45 Feb 12, 2007: Depuy Orthopaedics To Unveil S3 Shoulder Nail Plating System At American Academy Of Orthopaedic Surgeons Annual Meeting 176
15.6 Product Approvals 176
15.6.1 Aug 08, 2012: Codman Receives FDA PMA Approval For MEDSTREAM Programmable Infusion System 176
15.6.2 Feb 15, 2012: DePuy Receives FDA PMA Supplement Approval For TRUMATCH Personalized Solutions With SIGMA Rotating Platform Knee System 177
15.6.3 Aug 19, 2011: Depuy Receives FDA 510(k) Clearance For TRUMATCH Personalized Solutions 178
15.6.4 Feb 14, 2011: Depuy Receives FDA 510(K) Clearance For RECLAIM Revision Hip System 179
15.6.5 Feb 14, 2011: DePuy Receives FDA 510(k) Approval For New Titanium Foam Implants 179
15.7 Clinical Trials 180
15.7.1 Sep 25, 2007: Ankle Replacement Compares Favorably To Ankle Fusion According To A New Peer-Reviewed Study 180
15.8 Other Significant Developments 180
15.8.1 Oct 01, 2003: DePuy Renames Its DePuy AcroMed Division As DePuy Spine 180
16 Appendix 181
16.1 Research Methodology 182
16.2 Secondary Research 182
16.3 Primary Research 182
16.4 Models 183
16.5 Forecasts 183
16.6 Expert Panels 183
16.7 GlobalData Consulting 183
16.8 Currency Conversion 184
16.9 Contact Us 185
16.10 Disclaimer 185


【レポート販売概要】

■ タイトル:DePuy, Inc.:市場シェア分析
■ 英文:DePuy, Inc. Market Share Analysis
■ 発行日:2013年2月28日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160489
■ 調査対象地域:グローバル
  • 中国のIVD市場
    About In-vitro diagnostics (IVD) IVD procedures are conducted outside of a living organism in a test tube, petri dish, or culture dish. Whereas, in vivo diagnostics are carried out inside a living organism. IVD products are intended to collect biological samples such as blood, sputum, urine, spinal fluid, and DNA from a patient's body. They are analyzed in hospitals, clinics, and laboratories. IVD …
  • ライトプロジェクターの世界市場2016-2020
    About Light Projector Since 2012, technological innovations have improved image resolution, increased energy efficiency, and decreased space constraints with the development of portable Pico projectors. The emergence of light projectors has ensured that even small portal projectors can display images and videos with increased clarity. Further, embedded Pico projectors are likely to dominate the Pi …
  • マイクロフルイディクス(微少流体技術)の世界市場:材料(ポリマー、ガラス、シリコン)、用途、地域別分析
    Over the past five years, the microfluidics market has witnessed tremendous growth primarily due to rising demand for point-of-care (POC) testing, increasing use of miniaturized microfluidic chips to achieve faster testing and improved portability, and increased prevalence of age-related and lifestyle diseases and disorders. The global microfluidics market is expected to grow at a significant CAGR …
  • 世界のカミソリ及びカミソリ用刃市場(~2019):主要10か国
    This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for razors and razor blades in the world and in the top 10 global countries. Along with a global razor and razor blade market report the package includes country reports from the following countries: China, Czech Republic, France, Germany, India, Japan, Mexico, Poland, Uni …
  • 世界の無人航空機ペイロード(UAV Payload)市場動向2013-2023:市場規模及び成長要因
    The global UAV payload market valued US$4.0 billion in 2012 and is expected to increase at a CAGR of 4.4% during the forecast period, to reach its peak of US$6.1 billion by 2022. The market consists of three categories: radars and communication, sensors and detection, and weaponry. The radars and communication segment is expected to account for 45% of the global UAV payload market, followed by the …
  • 血友病の疫学的予測(~2024)
    EpiCast Report: Hemophilia - Epidemiology Forecast to 2024 Summary Hemophilia is an X-linked hereditary bleeding disorder, characterized by impaired blood coagulation as a result of deficiencies in the production or function of coagulation factor VIII (hemophilia A) or factor IX (hemophilia B). Because of the deficiency of coagulation factor, hemophilia patients have a tendency for bleeding in joi …
  • 世界の軍隊・軍事IT、データ、コンピューティング市場動向2013-2023:市場のSWOT分析
    This SWOT analysis of Military IT, Data and Computing market is a crucial resource for industry executives and anyone looking to gain a better understanding of the market. SDI's "The Global Military IT, Data and Computing Market 2012-2022 - SWOT Analysis: Market Profile" report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily acces …
  • クロロプレンゴム(CR)の世界市場2015-2019
    About Chloroprene Rubber Chloroprene rubber (CR) is an artificial polymer, which acts as an elastomer. Elastomers can experience significantly greater elastic deformation under anxiety and recovers its previous size without permanent deformation. CR has great mechanical quality, high ozone and weather resistance, great aging resistance, low flammability, great resistance toward chemicals, moderate …
  • 1-シクロヘキサンエタノールの世界市場2015
    1-Cyclohexylethanol (CAS 1193-81-3) Market Research Report 2015 aims at providing comprehensive data on 1-Cyclohexylethanol market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes 1-Cyclohexylethanol description, covers its application areas, manufacturing methods, patterns. It captures 1-Cyclohexylethanol market trends, pays close attention to 1-Cycloh …
  • フラッシュメモリカードの世界市場2015-2019
    About flash memory card Memory cards, also known as flash memory cards, are storage devices commonly used in cell phones, MP3 players, digital cameras, digital camcorders, tablets, gaming consoles, PDAs, and printers. They have non-volatile memory that can be reprogrammed multiple times in the course of their lifecycle. High density storage capability, quick read and write cycle, and small size ha …
  • コールドチェーンモニタリングの世界市場予測(~2022):構成要素別(ハードウェア、データロガー、センサー、RFID装置、テレメトリー、テレマティックス、ネットワーキング装置、ソフトウェア)、物流別、用途別、地域別
    According to the MarketsandMarkets forecast, the cold chain monitoring market is expected to grow from USD 3.11 Billion in 2015 to USD 6.23 Billion by 2022, at a CAGR of 9.84% between 2016 and 2022. Cold chain monitoring solutions are used in various applications such as pharmaceuticals and healthcare, food and beverages, and chemicals. The regulatory environment in the pharmaceutical industry to …
  • 世界のバイオシミラー市場動向と予測(~2018):Updated Version
    Biosimilars are therapeutically similar copies of biologic drugs. The European Medicines Agency (EMA) defines biosimilars as drugs that claim to be “similar” to their reference biological medicinal products. The active drug substance of biosimilars is derived from a living organism by means of recombinant DNA or controlled gene expression methods. In the coming years, biosimilars will continue to …
  • 世界の体外診断(IVD)市場
    The global in vitro diagnostics market was valued at $49.2 billion in 2012. The factors likely to fuel the growth of the market include ongoing developments in analytical laboratory automation, swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, and microbiology; and finally, the geographical market expansion w …
  • Viibryd (大うつ病性障害):医薬品市場予測及び分析(~2023)
    Viibryd (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for …
  • BAX-855 (Hemophilia A and B):市場予測と分析(~2022)
    BAX-855 (Hemophilia A and B) - Forecast and Market Analysis to 2022 Summary The competitive landscape of hemophilia A and B recombinant therapy in the US and 5EU is dominated by the use of recombinant FVIII and FIX replacement factors, and patients with severe forms of the disease receive frequent prophylactic infusions beginning from the first one or two years of life and often continuing through …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。